168 related articles for article (PubMed ID: 33502085)
1. Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.
Shimizu T; Kim DW; Loong HH; Lin CC; Ng MC; Yamamoto N; Ma B; Tan DS
Asia Pac J Clin Oncol; 2021 Aug; 17(4):388-395. PubMed ID: 33502085
[TBL] [Abstract][Full Text] [Related]
2. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study.
Gwee SXW; Chua PEY; Wang MX; Pang J
BMC Infect Dis; 2021 Aug; 21(1):799. PubMed ID: 34380452
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.
Rubio-San-Simón A; André N; Cefalo MG; Aerts I; Castañeda A; Benezech S; Makin G; van Eijkelenburg N; Nysom K; Marshall L; Gambart M; Hladun R; Rossig C; Bergamaschi L; Fagioli F; Carpenter B; Ducassou S; Owens C; Øra I; Ribelles AJ; De Wilde B; Guerra-García P; Strullu M; Rizzari C; Ek T; Hettmer S; Gerber NU; Rawlings C; Diezi M; Palmu S; Ruggiero A; Verdú J; de Rojas T; Vassal G; Geoerger B; Moreno L; Bautista F
Eur J Cancer; 2020 Dec; 141():82-91. PubMed ID: 33129040
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
6. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
[TBL] [Abstract][Full Text] [Related]
7. Effective COVID-19 Control: A Comparative Analysis of the Stringency and Timeliness of Government Responses in Asia.
Chen S; Guo L; Alghaith T; Dong D; Alluhidan M; Hamza MM; Herbst CH; Zhang X; Tagtag GCA; Zhang Y; Alazemi N; Saber R; Alsukait R; Tang S
Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444434
[TBL] [Abstract][Full Text] [Related]
8. Conducting a supportive oncology clinical trial during the COVID-19 pandemic: challenges and strategies.
Deng J; Lukens JN; Cohn JC; McMenamin E; Murphy B; Spinelli BA; Murphy N; Steinmetz AK; Landriau MA; Lin A
Trials; 2022 Nov; 23(1):927. PubMed ID: 36348346
[TBL] [Abstract][Full Text] [Related]
9. Mobile Apps Leveraged in the COVID-19 Pandemic in East and South-East Asia: Review and Content Analysis.
Lee B; Ibrahim SA; Zhang T
JMIR Mhealth Uhealth; 2021 Nov; 9(11):e32093. PubMed ID: 34748515
[TBL] [Abstract][Full Text] [Related]
10. Tourism under the Early Phase of COVID-19 in Four APEC Economies: An Estimation with Special Focus on SARS Experiences.
Tran BL; Chen CC; Tseng WC; Liao SY
Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081403
[TBL] [Abstract][Full Text] [Related]
11. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology.
Poon DM; Chan CK; Chan TW; Cheung FY; Ho LY; Kwong PW; Lee EK; Leung AK; Leung SY; So HS; Tam PC; Ma WK
Asia Pac J Clin Oncol; 2021 Apr; 17 Suppl 3(Suppl 3):48-54. PubMed ID: 33860643
[TBL] [Abstract][Full Text] [Related]
13. Navigating the challenges of the COVID-19 outbreak: Perspectives from the radiation oncology service in Singapore.
Tey J; Ho S; Choo BA; Ho F; Yap SP; Tuan JKL; Leong CN; Cheo T; Sommat K; Wang MLC
Radiother Oncol; 2020 Jul; 148():189-193. PubMed ID: 32342873
[TBL] [Abstract][Full Text] [Related]
14. Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes.
El Guerche-Séblain C; Chakir L; Nageshwaran G; Harris RC; Sevoz-Couche C; Vitoux O; Vanhems P
Travel Med Infect Dis; 2021; 44():102171. PubMed ID: 34648930
[TBL] [Abstract][Full Text] [Related]
15. Battling COVID-19 pandemic waves in six South-East Asian countries: A real-time consensus review.
Rampal L; Liew BS; Choolani M; Ganasegeran K; Pramanick A; Vallibhakara SA; Tejativaddhana P; Hoe VC
Med J Malaysia; 2020 Nov; 75(6):613-625. PubMed ID: 33219168
[TBL] [Abstract][Full Text] [Related]
16. The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.
Sessa C; Cortes J; Conte P; Cardoso F; Choueiri T; Dummer R; Lorusso P; Ottmann O; Ryll B; Mok T; Tempero M; Comis S; Oliva C; Peters S; Tabernero J
ESMO Open; 2022 Feb; 7(1):100339. PubMed ID: 34953404
[TBL] [Abstract][Full Text] [Related]
17. A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in Asia.
Otani K; Watanabe T; Higashimori A; Suzuki H; Kamiya T; Shiotani A; Sugimoto M; Nagahara A; Fukudo S; Motoya S; Yamaguchi S; Zhu Q; Chan FKL; Hahm KB; Tablante MC; Prachayakul V; Abdullah M; Ang TL; Murakami K;
Digestion; 2022; 103(1):7-21. PubMed ID: 34758472
[TBL] [Abstract][Full Text] [Related]
18. Perspectives on Oncology-Specific Language During the Coronavirus Disease 2019 Pandemic: A Qualitative Study.
Gharzai LA; Resnicow K; An LC; Jagsi R
JAMA Oncol; 2020 Sep; 6(9):1424-1428. PubMed ID: 32761102
[TBL] [Abstract][Full Text] [Related]
19. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
